comparemela.com

Latest Breaking News On - Volker herrmann - Page 1 : comparemela.com

Sonata Therapeutics Presents Data Supporting its Network Medicines™ Approach at SITC 2023

Sonata Therapeutics Presents Data Supporting its Network Medicines™ Approach at SITC 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Francesco-marincola
Ryan-shaler
Volker-herrmann
Carolyn-noyes
Maria-cristina-munteanu
Sonata-therapeutics-inc
Champalimaud-foundation
Network-medicines
Sonata-proprietary-intrinsic-antigen-release-technology
San-diego-convention-center-on
Sonata-network-medicines
Society-for-immunotherapy-of-cancer

Making the Transition from Academia to CEO

Making the Transition from Academia to CEO
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Switzerland
Berkeley
California
United-states
Canada
Montreal
Quebec
Judy-chou
James-mcarthur
Paula-ragan
Synovex-adheron
Ian-walters

Sonata Therapeutics Strengthens Leadership Team with Appointment of Francesco Marincola, M.D., as Chief Scientific Officer

Sonata Therapeutics Strengthens Leadership Team with Appointment of Francesco Marincola, M.D., as Chief Scientific Officer
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Milan
Lombardia
Italy
Jason-braco
Francesco-marincola
Volker-herrmann
Research-fellow-in-immune-oncology-at-abbvie
Society-for-immunotherapy-of-cancer
National-cancer-institute
National-institutes-of-health
Global-head-of-research-at-kite-pharma
Sonata-therapeutics-inc

Flagship merges two of its biotechs to form cellular microenvironment-focused Sonata

Sonata Therapeutics is developing drugs that reprogram cellular microenvironments to send signals intended to have curative effects. Cancer is the initial focus of the biotech, which Flagship Pioneering formed by combining two of its preclinical portfolio companies.

Cambridge
Cambridgeshire
United-kingdom
Massachusetts
United-states
Senda-biosciences
Volker-herrmann
Pearl-huang
Noubar-afeyan
Sonata-therapeutics
Flagship-pioneering-backed

vimarsana © 2020. All Rights Reserved.